Blis-To-Sol Tolnaftate Liquid Recalled for Manufacturing Practice Deviations
Ecometics, Inc. is recalling Blis-To-Sol Liquid (Tolnaftate) nationwide due to manufacturing practice violations. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries and no documented product defect. The hazard is a manufacturing practice deviation without specification of the underlying violation.
Plain-English summary
Ecometics, Inc. is recalling Blis-To-Sol Liquid (Tolnaftate), 1%, in two package sizes. The affected products are 1 fluid ounce (29.5 mL) bottles (UPC 0 11169 20011 8) and 1.85 fluid ounce (54.5 mL) bottles (UPC 0 11169 20012 5), lot 9E098A. Approximately 9,816 bottles of the 1 oz size and 10,776 bottles of the 1.85 oz size were distributed nationwide.
The FDA Class II recall was initiated because the product was not manufactured under current good manufacturing practices (CGMP).
Consumers who have purchased this product should stop using it and contact Ecometics, Inc. for return instructions. Patients needing treatment for fungal infections should consult their healthcare provider about alternative medications.
The recalled product
- Product
- Blis-To-Sol Liquid (Tolnaftate), 1%, packaged in a) 1 FLUID OZ. (29.5 mL) bottles, UPC 0 11169 20011 8 and b) 1.85 FLUID OZ. (54.5 mL) bottles, UPC 0 11169 20012 5, Distributed by Oakhurst Company, Levittown, NY 11756.
- Manufacturer
- Ecometics, Inc.
- Category
- Drug
- Hazard
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 9E098A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27